Solid-phase synthesis of naphthylamidines as factor VIIa/tissue factor inhibitors.
暂无分享,去创建一个
M. Morrissey | M. McCarrick | D. Light | B. Buckman | Raju Mohan | L. Trinh | K. Shaw | A. Liang | Dao Lentz | Y. Chou
[1] M. Bradley,et al. Inhibition of the tissue factor/factor VIIa complex — Lead optimisation using combinatorial chemistry , 1999 .
[2] M. Whitlow,et al. Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3, 5-difluoro-6-[3-(4, 5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]-N-methylgl y cine (ZK-807834): a potent, selective, and orally active inhibitor of the blood coagulation enzyme factor Xa. , 1998, Journal of medicinal chemistry.
[3] M. Morrissey,et al. Solid-phase synthesis of N-substituted amidinophenoxy pyridines as factor XA inhibitors. , 1998, Bioorganic & medicinal chemistry letters.
[4] Barry A. Bunin. The Combinatorial Index , 1998 .
[5] David W. Banner,et al. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor , 1996, Nature.
[6] L. C. Petersen,et al. Regulation of the extrinsic pathway system in health and disease: the role of factor VIIa and tissue factor pathway inhibitor. , 1995, Thrombosis research.
[7] P. Neuenschwander,et al. Roles of the membrane-interactive regions of factor VIIa and tissue factor. The factor VIIa Gla domain is dispensable for binding to tissue factor but important for activation of factor X. , 1994, The Journal of biological chemistry.
[8] P. Coleman,et al. Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates. , 1981, Methods in enzymology.